MYRIAD GENETICS, INC. Tax Withholding Paid on Stock Awards
MYRIAD GENETICS, INC. (MYGN) reported Tax Withholding Paid on Stock Awards of $3.30 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-31.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation · last filed 2026-07-31
- MYRIAD GENETICS, INC. payment, tax withholding, share-based payment arrangement for the quarter ending 2026-06-30 was $400.00K.
- MYRIAD GENETICS, INC. payment, tax withholding, share-based payment arrangement for the quarter ending 2026-03-31 was $2.90M, a 50.00% decline year-over-year.
- MYRIAD GENETICS, INC. payment, tax withholding, share-based payment arrangement for the quarter ending 2025-12-31 was $1.20M, a 0.00% change year-over-year.
- MYRIAD GENETICS, INC. payment, tax withholding, share-based payment arrangement for the quarter ending 2025-09-30 was $300.00K, a 90.00% decline year-over-year.
- MYRIAD GENETICS, INC. payment, tax withholding, share-based payment arrangement for fiscal 2025 was $7.30M, a 45.52% decline from fiscal 2024.
- MYRIAD GENETICS, INC. payment, tax withholding, share-based payment arrangement for fiscal 2024 was $13.40M, a 52.27% increase from fiscal 2023.
- MYRIAD GENETICS, INC. payment, tax withholding, share-based payment arrangement for fiscal 2023 was $8.80M, a 16.98% decline from fiscal 2022.
- MYRIAD GENETICS, INC. payment, tax withholding, share-based payment arrangement for fiscal 2022 was $10.60M, a 7.83% decline from fiscal 2021.
| Period end | Payment, Tax Withholding, Share-based Payment Arrangement 3 month | Payment, Tax Withholding, Share-based Payment Arrangement 6 month | Payment, Tax Withholding, Share-based Payment Arrangement 9 month | Payment, Tax Withholding, Share-based Payment Arrangement 12 month |
|---|---|---|---|---|
| 2026-06-30 | $400.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-31 | $3.30M 10-Q · filed 2026-07-31 | $4.50M derived: sum of 3 quarters · filed 2026-07-31 | $4.80M derived: sum of 4 quarters · filed 2026-07-31 |
| 2026-03-31 | $2.90M 10-Q · filed 2026-05-06 | $4.10M derived: sum of 2 quarters · filed 2026-05-06 | $4.40M derived: sum of 3 quarters · filed 2026-05-06 | $4.40M derived: sum of 4 quarters · filed 2026-07-31 |
| 2025-12-31 | $1.20M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $1.50M derived: sum of 2 quarters · filed 2026-02-24 | $1.50M derived: sum of 3 quarters · filed 2026-07-31 | $7.30M 10-K · filed 2026-02-24 |
| 2025-09-30 | $300.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $300.00K derived: sum of 2 quarters · filed 2026-07-31 | $6.10M 10-Q · filed 2025-11-04 | $7.30M derived: sum of 4 quarters · filed 2026-07-31 |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-31 | $5.80M 10-Q · filed 2026-07-31 | $7.00M derived: sum of 3 quarters · filed 2026-07-31 | $10.00M derived: sum of 4 quarters · filed 2026-07-31 |
| 2025-03-31 | $5.80M 10-Q · filed 2026-05-06 | $7.00M derived: sum of 2 quarters · filed 2026-05-06 | $10.00M derived: sum of 3 quarters · filed 2026-05-06 | $10.50M derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | $1.20M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $4.20M derived: sum of 2 quarters · filed 2026-02-24 | $4.70M derived: sum of 3 quarters · filed 2026-02-24 | $13.40M 10-K · filed 2026-02-24 |
| 2024-09-30 | $3.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $3.50M derived: sum of 2 quarters · filed 2025-11-04 | $12.20M 10-Q · filed 2025-11-04 | $13.70M derived: sum of 4 quarters · filed 2026-02-24 |
| 2024-06-30 | $500.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $9.20M 10-Q · filed 2025-08-06 | $10.70M derived: sum of 3 quarters · filed 2026-02-24 | $12.90M derived: sum of 4 quarters · filed 2026-02-24 |
| 2024-03-31 | $8.70M 10-Q · filed 2025-05-07 | $10.20M derived: sum of 2 quarters · filed 2026-02-24 | $12.40M derived: sum of 3 quarters · filed 2026-02-24 | $12.60M derived: sum of 4 quarters · filed 2026-02-24 |
| 2023-12-31 | $1.50M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $3.70M derived: sum of 2 quarters · filed 2026-02-24 | $3.90M derived: sum of 3 quarters · filed 2026-02-24 | $8.80M 10-K · filed 2026-02-24 |
| 2023-09-30 | $2.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | $2.40M derived: sum of 2 quarters · filed 2024-11-08 | $7.30M 10-Q · filed 2024-11-08 | $8.80M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-06-30 | $200.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | $5.10M 10-Q · filed 2024-08-07 | $6.60M derived: sum of 3 quarters · filed 2025-02-28 | $10.40M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-03-31 | $4.90M 10-Q · filed 2024-05-08 | $6.40M derived: sum of 2 quarters · filed 2025-02-28 | $10.20M derived: sum of 3 quarters · filed 2025-02-28 | $10.40M derived: sum of 4 quarters · filed 2025-02-28 |
| 2022-12-31 | $1.50M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $5.30M derived: sum of 2 quarters · filed 2025-02-28 | $5.50M derived: sum of 3 quarters · filed 2025-02-28 | $10.60M 10-K · filed 2025-02-28 |
| 2022-09-30 | $3.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $4.00M derived: sum of 2 quarters · filed 2023-11-07 | $9.10M 10-Q · filed 2023-11-07 | $12.00M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-06-30 | $200.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-04 | $5.30M 10-Q · filed 2023-08-04 | $8.20M derived: sum of 3 quarters · filed 2024-02-28 | $16.20M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-03-31 | $5.10M 10-Q · filed 2023-05-04 | $8.00M derived: sum of 2 quarters · filed 2024-02-28 | $16.00M derived: sum of 3 quarters · filed 2024-02-28 | $16.10M derived: sum of 4 quarters · filed 2024-02-28 |
| 2021-12-31 | $2.90M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $10.90M derived: sum of 2 quarters · filed 2024-02-28 | $11.00M derived: sum of 3 quarters · filed 2024-02-28 | $11.50M 10-K · filed 2024-02-28 |
| 2021-09-30 | $8.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-02 | $8.10M derived: sum of 2 quarters · filed 2022-11-02 | $8.60M 10-Q · filed 2022-11-02 | $8.60M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-06-30 | $100.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-05 | $600.00K 10-Q · filed 2022-08-05 | $600.00K derived: sum of 3 quarters · filed 2023-03-01 | $4.40M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-03-31 | $500.00K 10-Q · filed 2022-05-06 | $500.00K derived: sum of 2 quarters · filed 2023-03-01 | $4.30M derived: sum of 3 quarters · filed 2023-03-01 | $4.30M derived: sum of 4 quarters · filed 2023-03-01 |
| 2020-12-31 | $0.00 derived: 10-K 6 month − 10-Q 3 month · filed 2023-03-01 | $3.80M 10-K · filed 2023-03-01 | $3.80M derived: sum of 3 quarters · filed 2023-03-01 | $3.90M derived: sum of 4 quarters · filed 2023-03-01 |
| 2020-09-30 | $3.80M 10-Q · filed 2020-11-09 | $3.80M derived: sum of 2 quarters · filed 2021-08-04 | $3.90M 10-Q · filed 2021-11-04 | |
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-04 | $100.00K 10-Q · filed 2021-08-04 | $9.80M 10-K · filed 2023-03-01 | |
| 2020-03-31 | $100.00K 10-Q · filed 2021-05-05 | |||
| 2019-09-30 | $400.00K 10-Q · filed 2020-11-09 | |||
| 2019-06-30 | $14.50M 10-K · filed 2022-02-25 | |||
| 2018-06-30 | $8.40M 10-KT · filed 2021-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |